0

Nerve Repair and Regeneration Market by Product, Application, and Geography - Forecast and Analysis 2023-2027

  • Published: Nov 2022
  • Pages: 153
  • SKU: IRTNTR74728
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The nerve repair and regeneration market is estimated to grow at a CAGR of 11.23% between 2022 and 2027. The size of the market is forecast to increase by USD 4,891.9 million. The growth of the market depends on serval factors, including the rising prevalence of neurological disorders, increasing government funds for research on neurological diseases, and expansion of neurology-related research projects.

This report extensively covers market segmentation by product (neuromodulation devices and biomaterials), application (neurorrhaphy, nerve grafting, and stem cell therapy), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the Size of the Nerve Repair And Regeneration Market During the Forecast Period?

Nerve Repair and Regeneration Market Size

To learn more about this report, Download Report Sample

Parent Market Analysis

The reports categorize the global nerve repair and regeneration market as a part of the global healthcare equipment market. The parent, global healthcare equipment market, covers products and companies engaged in research and development (R and D) of a variety of product categories, including capital equipment, instruments, implants, accessories, and consumables that are used for the diagnosis, monitoring, and treatment of various diseases. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.

Nerve Repair And Regeneration Market: Key Drivers, Trends, Challenges, and Customer Landscape

The rising prevalence of neurological disorders is notably driving the market growth, although factors such as the dearth of trained professionals may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Nerve Repair And Regeneration Market Driver

The rising prevalence of neurological disorders is notably driving the market growth. The nerve repair and regeneration market is expanding due to the rising prevalence of neurological illnesses like Alzheimer's disease across the world. Globally, the leading cause of impairment is neurological illnesses. According to the Centers for Disease Control and Prevention, about 5.8 million Americans suffered from Alzheimer's disease in 2020 in the US. Additionally, the aging population, which is more susceptible to these conditions, and the rising number of nerve injuries are boosting market expansion. Innovative nerve repair solutions are being offered by hospitals, ambulatory surgical centers (ASCs), and other healthcare organizations globally for the quick diagnosis and treatment of neurological illnesses.

Although physiological aging begins after the age of 60, the frequency of neurological disorders has increased due to the expanding older population. The communication between the brain and muscles and organs is hampered due to damaged nerves. The replacement of injured neural tissue, cells, and cellular byproducts is offered through nerve repair and regeneration. New axons, myelin, neurons, glial cells, and synapses are also produced as part of the nerve repair and regeneration process. Thus, the rising prevalence of neurological disorders is driving the market during the forecast period.

Key Nerve Repair And Regeneration Market Trend

Technological advancements for nerve repair and regeneration are the key trend in the market. The market for nerve repair and regeneration is expanding as a result of technological developments in the healthcare sector. Other growth-promoting variables include numerous technological developments in stem cell therapy and the creation of novel neuromodulation devices. Endogenous stem cells are often used in neurogenesis, neural repair, and exogenous neural stem cell transplantation for the effective repair and replacement of damaged tissues in the central nervous system. The market is expected to rise as a result of a number of additional factors, including rising consumer healthcare spending and significant improvements in medical infrastructure, particularly in developing countries.

Additionally, organizations with public and private funding are conducting clinical trials to create a secure and efficient treatment for various neurological conditions. Examples include the use of stem cells in umbilical blood infusion for cerebral palsy (Phase II) and the use of polyethylene glycol (PEG) drug in Phase I to support the axonal fusion technique to treat peripheral nerve injuries in people. For instance, the Australian government invested $21.8 million in research in 2020 to find cures for a variety of neurological conditions, such as autism and early Alzheimer's disease. Thus, technological advancement for nerve repair and regeneration will grow the market during the forecast period.

Key Nerve Repair And Regeneration Market Challenge

The dearth of trained professionals is the major challenge impeding the market growth. A number of market constraints affect the growth of the market, such as the lack of trained experts. Due to the huge gap between the requirement for and availability of neurologists globally, there is a scarcity of skilled specialists. Donors' nerves are commonly affected by tissue morbidity, which is a significant concern. It is difficult to use nerve conduits to close neural gaps larger than 3 cm. Depending on the application, devices for neurostimulation and neuromodulation may fall under Class 2 or Class 3 medical devices and need premarket approval.

The World Health Organization estimates that about 25% of currently employed health professionals lack the necessary credentials. As the need for healthcare services rises and the industry adopts new technologies, there is a shortage of workers with digital technological skills, which further hinders their capacity to handle nerve repair and regeneration technology. The COVID-19 pandemic has also shown that the healthcare resources allocated to the management of the pandemic in urban and rural areas directly compete with the crucial medical, surgical, interventional, and interventional diagnostic services for other diseases, such as neurological diseases. Thus, the lack of trained professionals will act as a challenge for the market during the forecast period.

Key Nerve Repair And Regeneration Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Nerve Repair and Regeneration Market Share by Geography

Global Nerve Repair and Regeneration Market Customer Landscape

Who are the Major Nerve Repair and Regeneration Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories - The company offers solutions for nerve repair regeneration by eliminating the time required for harvesting an autograft using modern technology. Under this segment, the company also offers products for rhythm management, electrophysiology, heart failure, vascular, structural heart, and neuromodulation. Additionally, Under the diagnostic segment, the company focuses on core laboratory, molecular solutions, point-of-care solutions, and rapid diagnostics.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • ALEVA NEUROTHERAPEUTICS SA
  • AxoGen Inc.
  • Baxter International Inc.
  • BioWaveGO USA
  • Boston Scientific Corp.
  • Check Point Surgical Inc.
  • Collagen Matrix Inc.
  • Gimer Medical Co. Ltd.
  • Integra Lifesciences Holdings Corp.
  • KeriMedical SA
  • LivaNova Plc
  • Medtronic Plc
  • NEURONETICS Inc.
  • NeuroPace Inc.
  • NeuroSigma Inc.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Nerve Repair And Regeneration Market?

The market share growth of the neuromodulation device segment will be significant during the forecast period. Neuromodulation is a technique that targets nerve injury by sending electrical impulses to the affected area. Neuromodulation surgical devices are well-known in the healthcare industry and have a high market share. The supply chain interruptions induced by the pandemic had a significant influence on neuromodulation devices, which had a positive impact on the demand for neuromodulation surgery devices across the world in 2020. 

Nerve Repair and Regeneration Market Size

Get a glance at the market contribution of various segments Request a PDF Sample

The neuromodulation device segment was valued at USD 2,465.30 million in 2017 and continues to grow until 2021The neuromodulation devices segment is further subdivided into internal neurostimulation devices and external neurostimulation devices. Internal neurostimulation devices include spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, and sacral nerve stimulation. External neurostimulation devices include transcutaneous electrical nerve stimulation devices, transcranial magnetic stimulation devices, and respiratory electrical stimulation devices. 

The neuromodulation devices segment holds the highest market share in 2022 and is expected to have the highest CAGR during the forecast period. The growing prevalence of neurological illnesses increased the adoption of neurostimulation and neuromodulation devices, and innovations are driving the expansion of the market during the forecast period.

Which are the Key Regions for the Nerve Repair And Regeneration Market?

Nerve Repair and Regeneration Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

North America is projected to contribute 32% by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The US is the major contributor to the nerve repair and regeneration market in North America, owing to the rising capital expenditure on treating patients with neurological disorders such as epilepsy and dementia and the growing demand for neuromodulation devices. According to the Annals of Neurology, neurological disorders exert a financial burden on the healthcare system in the US, which accounts for spending approximately $800 billion every year. The increasing number of patients with neurological disorders and the increasing cost of treatment in the US are expected to boost market growth during the forecast period. The high fiscal healthcare expenditure and advanced healthcare infrastructure are significant contributors to regional market growth.

The outbreak of COVID-19 in 2020 had a negative impact on the regional market. However, in 2021, business and industrial activities resumed with the relaxation of stringent lockdown restrictions due to the availability of COVID-19 vaccines and the vaccination drives carried out by the governments of countries such as the US, Canada, and Mexico. Clinics and hospitals resumed nerve repair and regeneration procedures with proper safety and precautions in mid-2021. Such initiatives increased the demand for neurostimulation devices. A major factor driving market expansion is the rise in the number of cases of Alzheimer's and dementia across the region, which will fuel the growth of the market during the forecast period.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by Product (Neuromodulation devices and Biomaterials), Application (Neurorrhaphy, Nerve grafting, and Stem cell therapy), and Geography (North America, Europe, Asia, and Rest of World (ROW)).

  • Product Outlook (USD Million, 2017 - 2027)
    • Neuromodulation devices
    • Biomaterials
  • Application Outlook (USD Million, 2017 - 2027)
    • Neurorrhaphy
    • Nerve grafting
    • Stem cell therapy
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
      • Singapore
    • Rest of World (ROW))
      • Brazil
      • Argentina
      • Rest of the Middle East & Africa

Nerve Repair And Regeneration Market Scope

Report Coverage

Details

Page number

153

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 11.23%

Market growth 2023-2027

USD 4,891.9 million

Market structure

Fragmented

YoY growth (%)

10.89

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 32%

Key countries

US, Canada, Germany, China, Japan, and India

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, AxoGen Inc., Baxter International Inc., BioWaveGO USA, Boston Scientific Corp., Check Point Surgical Inc., Collagen Matrix Inc., Gimer Medical Co. Ltd., Integra Lifesciences Holdings Corp., KeriMedical SA, LivaNova Plc, Medtronic Plc, NEURONETICS Inc., NeuroPace Inc., NeuroSigma Inc., Polyganics BV, Soterix Medical Inc., Stryker Corp., and Synapse Biomedical Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Nerve Repair And Regeneration Market Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the nerve repair and regeneration market between 2023 and 2027
  • Precise estimation of the size of the nerve repair and regeneration market size and its contribution to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of nerve repair and regeneration market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global nerve repair and regeneration market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global nerve repair and regeneration market 2017 - 2021 ($ million)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.3 Application Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Neuromodulation devices - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Neuromodulation devices - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Neuromodulation devices - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Neuromodulation devices - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Neuromodulation devices - Year-over-year growth 2022-2027 (%)
    • 6.4 Biomaterials - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Biomaterials - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Biomaterials - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Biomaterials - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Biomaterials - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ million)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 43: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on Application - Market share 2022-2027 (%)
    • 7.2 Comparison by Application
      • Exhibit 45: Chart on Comparison by Application
      • Exhibit 46: Data Table on Comparison by Application
    • 7.3 Neurorrhaphy - Market size and forecast 2022-2027
      • Exhibit 47: Chart on Neurorrhaphy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Data Table on Neurorrhaphy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Chart on Neurorrhaphy - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on Neurorrhaphy - Year-over-year growth 2022-2027 (%)
    • 7.4 Nerve grafting - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Nerve grafting - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Data Table on Nerve grafting - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Chart on Nerve grafting - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Nerve grafting - Year-over-year growth 2022-2027 (%)
    • 7.5 Stem cell therapy - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Stem cell therapy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Stem cell therapy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Stem cell therapy - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Stem cell therapy - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Application
      • Exhibit 59: Market opportunity by Application ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 61: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 63: Chart on Geographic comparison
      • Exhibit 64: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 India - Market size and forecast 2022-2027
      • Exhibit 101: Chart on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 102: Data Table on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 103: Chart on India - Year-over-year growth 2022-2027 (%)
      • Exhibit 104: Data Table on India - Year-over-year growth 2022-2027 (%)
    • 9.13 Market opportunity by geography
      • Exhibit 105: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 106: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 108: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 109: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 110: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 111: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 112: Abbott Laboratories - Overview
              • Exhibit 113: Abbott Laboratories - Business segments
              • Exhibit 114: Abbott Laboratories - Key news
              • Exhibit 115: Abbott Laboratories - Key offerings
              • Exhibit 116: Abbott Laboratories - Segment focus
            • 12.4 ALEVA NEUROTHERAPEUTICS SA
              • Exhibit 117: ALEVA NEUROTHERAPEUTICS SA - Overview
              • Exhibit 118: ALEVA NEUROTHERAPEUTICS SA - Product / Service
              • Exhibit 119: ALEVA NEUROTHERAPEUTICS SA - Key offerings
            • 12.5 AxoGen Inc.
              • Exhibit 120: AxoGen Inc. - Overview
              • Exhibit 121: AxoGen Inc. - Product / Service
              • Exhibit 122: AxoGen Inc. - Key offerings
            • 12.6 Baxter International Inc.
              • Exhibit 123: Baxter International Inc. - Overview
              • Exhibit 124: Baxter International Inc. - Business segments
              • Exhibit 125: Baxter International Inc. - Key news
              • Exhibit 126: Baxter International Inc. - Key offerings
              • Exhibit 127: Baxter International Inc. - Segment focus
            • 12.7 Boston Scientific Corp.
              • Exhibit 128: Boston Scientific Corp. - Overview
              • Exhibit 129: Boston Scientific Corp. - Business segments
              • Exhibit 130: Boston Scientific Corp. - Key news
              • Exhibit 131: Boston Scientific Corp. - Key offerings
              • Exhibit 132: Boston Scientific Corp. - Segment focus
            • 12.8 Collagen Matrix Inc.
              • Exhibit 133: Collagen Matrix Inc. - Overview
              • Exhibit 134: Collagen Matrix Inc. - Product / Service
              • Exhibit 135: Collagen Matrix Inc. - Key offerings
            • 12.9 Integra Lifesciences Holdings Corp.
              • Exhibit 136: Integra Lifesciences Holdings Corp. - Overview
              • Exhibit 137: Integra Lifesciences Holdings Corp. - Business segments
              • Exhibit 138: Integra Lifesciences Holdings Corp. - Key news
              • Exhibit 139: Integra Lifesciences Holdings Corp. - Key offerings
              • Exhibit 140: Integra Lifesciences Holdings Corp. - Segment focus
            • 12.10 LivaNova Plc
              • Exhibit 141: LivaNova Plc - Overview
              • Exhibit 142: LivaNova Plc - Business segments
              • Exhibit 143: LivaNova Plc - Key offerings
              • Exhibit 144: LivaNova Plc - Segment focus
            • 12.11 Medtronic Plc
              • Exhibit 145: Medtronic Plc - Overview
              • Exhibit 146: Medtronic Plc - Business segments
              • Exhibit 147: Medtronic Plc - Key news
              • Exhibit 148: Medtronic Plc - Key offerings
              • Exhibit 149: Medtronic Plc - Segment focus
            • 12.12 NEURONETICS Inc.
              • Exhibit 150: NEURONETICS Inc. - Overview
              • Exhibit 151: NEURONETICS Inc. - Product / Service
              • Exhibit 152: NEURONETICS Inc. - Key offerings
            • 12.13 NeuroPace Inc.
              • Exhibit 153: NeuroPace Inc. - Overview
              • Exhibit 154: NeuroPace Inc. - Product / Service
              • Exhibit 155: NeuroPace Inc. - Key offerings
            • 12.14 Polyganics BV
              • Exhibit 156: Polyganics BV - Overview
              • Exhibit 157: Polyganics BV - Product / Service
              • Exhibit 158: Polyganics BV - Key offerings
            • 12.15 Soterix Medical Inc.
              • Exhibit 159: Soterix Medical Inc. - Overview
              • Exhibit 160: Soterix Medical Inc. - Product / Service
              • Exhibit 161: Soterix Medical Inc. - Key offerings
            • 12.16 Stryker Corp.
              • Exhibit 162: Stryker Corp. - Overview
              • Exhibit 163: Stryker Corp. - Business segments
              • Exhibit 164: Stryker Corp. - Key news
              • Exhibit 165: Stryker Corp. - Key offerings
              • Exhibit 166: Stryker Corp. - Segment focus
            • 12.17 Synapse Biomedical Inc.
              • Exhibit 167: Synapse Biomedical Inc. - Overview
              • Exhibit 168: Synapse Biomedical Inc. - Product / Service
              • Exhibit 169: Synapse Biomedical Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 170: Inclusions checklist
                • Exhibit 171: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 172: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 173: Research methodology
                • Exhibit 174: Validation techniques employed for market sizing
                • Exhibit 175: Information sources
              • 13.5 List of abbreviations
                • Exhibit 176: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Nerve Repair and Regeneration market growth will increase by $4891.9 million during 2023-2027.
              The nerve repair and regeneration market is expected to grow at a CAGR of 11.23% during 2023-2027.
              Technavio has segmented the nerve repair and regeneration market by product (Neuromodulation devices and Biomaterials) ,application (Neurorrhaphy, Nerve grafting, and Stem cell therapy) , and geography (North America, Europe, Asia, and Rest of World (ROW)).
              Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, AxoGen Inc., Baxter International Inc., BioWaveGO USA, Boston Scientific Corp., Check Point Surgical Inc., Collagen Matrix Inc., Gimer Medical Co. Ltd., Integra Lifesciences Holdings Corp., KeriMedical SA, LivaNova Plc, Medtronic Plc, NEURONETICS Inc., NeuroPace Inc., NeuroSigma Inc., Polyganics BV, Soterix Medical Inc., Stryker Corp., Synapse Biomedical Inc. are a few of the key vendors in the nerve repair and regeneration market.
              North America will register the highest growth rate of 32.42% among the other regions. Therefore, the nerve repair and regeneration market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the nerve repair and regeneration market growth are:
              • Rising prevalence of neurological disorders
              • Technological advancements for nerve repair and regeneration
              The nerve repair and regeneration market vendors should focus on grabbing business opportunities from the neuromodulation devices segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>